Program shows strong global engagement and a clear path from learning to hands-on adoption with QNX Everywhere NUREMBERG, GERMANY / ACCESS Newswire / March 11, 2026 / QNX, a division of BlackBerry ...

The U.S. wellness economy now exceeds $1 trillion, with racquet sports, Pilates, and recovery among the fastest-growing segments. Fitura Brands was designed as a multi-concept franchise platform ...

The MacBook Neo proves that macOS can run on an iPhone processor. More than that, it shows how Apple now has all of the elements to make a device that's transformative in every sense. Imagine only ...

NEGROS OCCIDENTAL (PIA) — The 3rd Infantry (Spearhead) Division (3ID) of the Philippine Army (PA) has reiterated its call for rebel remnants here to cease armed confrontation with state troops and ...

The tool displays organs in three dimensions and opens new avenues for researching key diseases, such as cancer and diabetes ...

MindHYVE.aitm, Inc. and California Northstate University (CNU) have signed a Strategic Collaboration Framework (SCF) to deploy ArthurAItm, MindHYVE's Agentic Learning OS, within CNU's College of ...

Sprout Social, Inc. ( SPT) Discusses Platform Architecture and AI Strategy for System of Record and Action March 11, 2026 11:00 AM EDT All right. Thank you, and welcome to Sprout Social's discussion ...

This expanded application of the Atropos Evidence Agent, an expert real-world evidence agent, is already live at Stanford Medicine.“It’s like the Atropos Evidence Agent is reading my mind,” said Dr.

Unreasonable Labs Raises $13.5M to scale its AI discovery engine and accelerate innovation across science and engineering.

BlackBerry BB shares are up during Wednesday’s premarket session. The company disclosed the expansion of its online learning platform to enhance developer readiness. QNX Platform Expansion Boosts ...

In a world where AI can easily perform financial analysis, Datarails is betting that governance of data and financial models will be its key differentiator ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...